191 related articles for article (PubMed ID: 18284394)
1. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
Gómez-Outes A; Gómez de la Bárcena C; Martínez-González J
Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
[No Abstract] [Full Text] [Related]
2. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
[TBL] [Abstract][Full Text] [Related]
3. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
Jappe U
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Koch P
Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
6. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
7. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
Schiffner R; Glässl A; Landthaler M; Stolz W
Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
[No Abstract] [Full Text] [Related]
8. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
9. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
10. The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17.
Ludwig RJ; Schindewolf M; Lindhoff-Last E; Boehncke WH
Br J Dermatol; 2008 Apr; 158(4):849-51. PubMed ID: 18205866
[No Abstract] [Full Text] [Related]
11. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
Figarella I; Barbaud A; Lecompte T; De Maistre E; Reichert-Penetrat S; Schmutz JL
Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
[TBL] [Abstract][Full Text] [Related]
13. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
[No Abstract] [Full Text] [Related]
14. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
[No Abstract] [Full Text] [Related]
15. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE
Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521
[No Abstract] [Full Text] [Related]
16. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
Jappe U; Reinhold D; Bonnekoh B
Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
[TBL] [Abstract][Full Text] [Related]
17. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
Harr T; Scherer K; Tsakiris DA; Bircher AJ
Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
[No Abstract] [Full Text] [Related]
18. Delayed-type skin reaction to the heparin-alternative danaparoid.
Szolar-Platzer C; Aberer W; Kränke B
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
[TBL] [Abstract][Full Text] [Related]
19. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
Tan E; Thompson G; Ekstrom C; Lucas M
Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
Irion R; Gall H; Peter RU
Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
